News
The FreeStyle Libre 3 Sensor: A Discrete Soluti...
Introducing the FreeStyle Libre 3 Sensor: A Discrete Solution for Monitoring Glucose Levels For people with diabetes, monitoring glucose levels is a crucial part of daily life. However, traditional glucose...
The FreeStyle Libre 3 Sensor: A Discrete Soluti...
Introducing the FreeStyle Libre 3 Sensor: A Discrete Solution for Monitoring Glucose Levels For people with diabetes, monitoring glucose levels is a crucial part of daily life. However, traditional glucose...
TARGETING STEM CELL-GENERATED BETA CELLS FOR TY...
KEY POINTS: A recent study may have found a way to improve the number and quality of beta cells produced for cell replacement therapy. Researchers found that by adding CD77 they can...
TARGETING STEM CELL-GENERATED BETA CELLS FOR TY...
KEY POINTS: A recent study may have found a way to improve the number and quality of beta cells produced for cell replacement therapy. Researchers found that by adding CD77 they can...
COULD THERE BE MORE THAN ONE FORM OF TYPE 1 DIA...
KEY POINTS: There are significant differences between type 1 diabetes (T1D) and type 2 diabetes (T2D). According to a recent study, there may be more than one endotype, and a major...
COULD THERE BE MORE THAN ONE FORM OF TYPE 1 DIA...
KEY POINTS: There are significant differences between type 1 diabetes (T1D) and type 2 diabetes (T2D). According to a recent study, there may be more than one endotype, and a major...
RECAPPING CURRENT RESEARCH REGARDING TYPE 1 DIA...
KEY POINTS: Researchers revealed new studies regarding the potential role of long non-coding RNAs (lncRNAs) in the development of type 1 diabetes. A recent study shows that lncRNA may be involved...
RECAPPING CURRENT RESEARCH REGARDING TYPE 1 DIA...
KEY POINTS: Researchers revealed new studies regarding the potential role of long non-coding RNAs (lncRNAs) in the development of type 1 diabetes. A recent study shows that lncRNA may be involved...
NEW ORAL TREATMENT MAY HELP WITH MANAGING HBA1C...
KEY POINTS: A recent study shows that one pill a day used in conjunction with insulin may help reduce HbA1c levels by as much as 0.32% after 12 weeks. The pill...
NEW ORAL TREATMENT MAY HELP WITH MANAGING HBA1C...
KEY POINTS: A recent study shows that one pill a day used in conjunction with insulin may help reduce HbA1c levels by as much as 0.32% after 12 weeks. The pill...
COULD INSULIN-PRODUCING BETA CELLS PLAY A ROLE ...
Researchers know that type 1 diabetes (T1D) occurs when the immune system mistakenly attacks and destroys insulin-producing beta cells. This leaves the body unable to self-regulate blood glucose levels because...
COULD INSULIN-PRODUCING BETA CELLS PLAY A ROLE ...
Researchers know that type 1 diabetes (T1D) occurs when the immune system mistakenly attacks and destroys insulin-producing beta cells. This leaves the body unable to self-regulate blood glucose levels because...